Summary:
A Phase I clinical trial to evaluate the safety and tolerability of VLP Peanut in healthy subjects and subjects with peanut allergy and to explore preliminary signals of its efficacy.
Qualified Participants Must:
• Be 18-50 years old
•
Be in good health
•
Be at least 154 pounds
Qualified Participants May Receive:
Compensation for time and travel.
No insurance necessary and transportation provided.